Odyssean »

Atrium Therapeutics shares owned by Odyssean

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $286k 21k 13.45

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Atrium Therapeutics

T. Rowe Price Associates
BlackRock
Susquehanna International
Vanguard Capital Management
CRCM
TIG Advisors
Sessa Capital IM
Farallon Capital Management
Two Sigma Investments
Geode Capital Management
Goldman Sachs Group
683 Capital Management
Bellevue Group
State Street Corporation
Weiss Asset Management LP[1

View all funds holding Atrium Therapeutics